| Proteros–SEVERAL: investment, 201208 3rd financing round €5m led by BayBG + incl two new investors |
2012-08-06 |
| Paragon Bioservices–Cevec: CAP technology, 201208– license to CAP + CAP-T cell expression systems for contract production of rec proteins + antibodies |
2012-08-02 |
| BlueGenics project–EU (govt): grant, 201208–201607 funding €6m out of total project cost of €8.45m |
2012-08-01 |
| AutoBio project–Germany (govt): grant, 201207–2015 BMBF grant for 3 years for programme with total volume of €3.7m |
2012-07-31 |
| Rentschler–MHH: gene therapy vector system, 201207 license for commercialisation of vector system developed by Prof Baum et al |
2012-07-25 |
| Antisense Pharma–MC Services: public relations, 201207 service existent for Antisense Pharma GmbH |
2012-07-24 |
| Evonik–BioAmber: catalysts, 201207– collab long-term developm + manufacturing of catalysts to use bio-based succinic acid |
2012-07-24 |
| SuppreMol–Germany (govt): grant, 201207– BMBF grant €1.37m for early development of SM401 within m4 cluster initiative |
2012-07-24 |
| SuppreMol–Univ Regensburg: anti-IL-3 MAb, 201207– license developm for therapy + diagnosis of RA via Bayerische Patentallianz GmbH |
2012-07-24 |
| Boehringer–Funxional Therapeutics: anti-inflammatory drugs, 201207 acquisition €na global rights for FX125L + somatotaxin portfolio |
2012-07-23 |
| Fenwal–Fresenius: investment, 201207– acquisition €na of Fenwal Holdings Inc by Fresenius Kabi from TPG + Maverick Capital |
2012-07-20 |
| Advanced Technology Company–Curetis: Unyvero platform, 201207– distribution by ATC in all 6 GCC countries + Lebanon |
2012-07-18 |
| c-LEcta–Aquapharm: biocatalysts, 201207– collab developm + commercialisation of marine-derived biocatalysts part-supported by Eurostars grant |
2012-07-18 |
| Genetrix (ES)–Sygnis: investment, 201207–201212 acquisition of X-Pol by Sygnis via reverse merger w X-Pol holding 77.5% of Sygnis after closing |
2012-07-18 |
| Univ Luxembourg–Biobase: bioinformatics, 201207– supply + collab use of Genome Trax by LCSB to analyse NGS data in clinical diagnostics |
2012-07-17 |
| Qiagen–Genetrix (ES): DNA polymerase, 201207– license excl ww for Qualifi polymerase from X-Pol Biotech |
2012-07-16 |
| Subitec–High-Tech Gründerfonds: investment, 201207 2nd financing round totalling €4.5m incl co-investor HTGF |
2012-07-16 |
| Subitec–SEVERAL: investment, 201207 2nd financing round €4.5m led by eCapital Entrepreneurial Partners AG |
2012-07-16 |
| Xtal Concepts–Hamburg (govt): investment, 201207 investment in Xtal Concepts GmbH by Innovationsstarter Fonds Hamburg |
2012-07-16 |
| Labor Diagnostik Leipzig–Qiagen: investment, 201207 acquisition by Qiagen |
2012-07-15 |
| Epivios–High-Tech Gründerfonds: investment, 201207 seed financing round from HTGF + LSI Pre-Seed-Fonds + TTHU + private investor |
2012-07-11 |
| Epivios–SEVERAL: investment, 201207 seed financing round from HTGF + LSI Pre-Seed-Fonds + TTHU + private investor |
2012-07-11 |
| Boehringer–Healthrageous: digital health management, 201207– collab digital diabetes self-management programme |
2012-07-10 |
| Helmholtz–Metabolon: mass spectrometry technology, 201207– collab Joint Metabolomics Laboratory at Helmholtz Zentrum München in Neuherberg |
2012-07-10 |
| Mologen–SEVERAL: investment, 201207 capital increase €22m gross proceeds 2,589,819 shares €8.5/share |
2012-07-10 |
| Bayer–Horizon Discovery: Genesis technology, 201207– collab €na development of pre-clinical cell line models for oncology research using Genesis |
2012-07-09 |
| Boehringer–Harvard Univ: drug research, 201207– collab funding of serveral translational research projects at Harvard by BI |
2012-07-09 |
| KWS Saat–Two Blades Foundation: TAL Code technology, 201207– non-excl commercial license €na to KWS Saat AG commercial use in certain crop plants |
2012-07-09 |
| Medicyte–Reinnervate: cell research technology, 201207– collab €na product integration of upcyte + Alevtex Scaffold technologies |
2012-07-09 |
| Sinphar Pharmaceutical–Medigene: EndoTAG-1, 201207– collab excl co-developm + commercialisation by SynCore Biotechnology in Asia, AUS + NZ |
2012-07-06 |
| Merck (DE)–MDxHealth: molecular companion diagnostics, 201207– collab expansion €na ww developm + commerc PredictMDx for Glioblastoma w cilengitide |
2012-07-05 |
| 4SC–SEVERAL: investment, 201207 capital increase up to 8.4m new shares €12.6m €1.5/share |
2012-07-04 |
| AgraQuest–Bayer: investment, 201207–201208 acquisition $425m + milestones by Bayer CropScience |
2012-07-03 |
| Euroimmun–Taylor Wessing: legal services, 201207 advisor to Euroimmun with regard to acquisition of GMK (BR) by Euroimmun |
2012-07-03 |
| GMK (BR)–Euroimmun: investment, 201207 acquisition 100% €na by Euroimmun Medizinische Labordiagnostik AG |
2012-07-03 |
| Procognia–Scienion: print/spotting technology, 201207 supply use sciFlexarrayer to produce Multi Pad GlycoScope lectin microarray |
2012-07-02 |
| Paion–Germany (govt): grant, 201207–201412 KMU-Innovativ BMBF grant €700k for developm of thrombomodulin-mutants |
2012-07-01 |
| Re-Liver project–EU (govt): grant, 201207c– FP7 grant €4.2m for developm of biomimetic bioartificial liver |
2012-07-01 |
| Corimmun–JnJ: investment, 201206 acquisition €100m + milestones durch Janssen-Cilag GmbH |
2012-06-28 |
| Anagnostics–Kompass: molecular diagnostics, 201206– collab + license for SepsiTest sample prep kit to develop hybcell Pathogens DNA |
2012-06-27 |
| Courtagen–Scienion: print/spotting technology, 201206 supply use sciFlexarrayer S11 to produce QDx BioChips for Avantra Q400 Biomarker Workstation |
2012-06-25 |
| Qiagen–SAP: bioinformatics, 201206– collab application of SAP HANA platform for analysis of sequencing data |
2012-06-25 |
| NEU² project–Epomedics: MS drug RnD, 201206– collab Epomedics GmbH becomes project member |
2012-06-22 |
| Zedira–R-Biopharm: investment, 201206 existent investor is R-Biopharm AG |
2012-06-22 |
| Peqlab–Eppendorf: thermal cycler, 201206– license covering gradient technology for thermal cyclers to Peqlab |
2012-06-21 |
| NatLifE 2020 project–Germany (govt): grant, 201206– up to 9y funding from BMBF under Industrial Biotechnology Innovation Initiative |
2012-06-18 |
| Vela–Eppendorf: automated liquid handling, 201206 collab joint developm of Sentosa SX system based on epMotion system for Vela Diagnostics |
2012-06-18 |
| Topsfield Medical–High-Tech Gründerfonds: investment, 201206 seed financing from HTGF |
2012-06-14 |
| Bayer–Abbott & Cobb: seeds, 201206 acquisition €na of watermelon + melon seed business by Bayer CropScience |
2012-06-12 |
| Enzymicals–BBG/Braun Group: investment, 201206 acquisition of stake in Enzymicals AG by Braun Beteiligungs GmbH |
2012-06-08 |
| Enzymicals–BRAIN: investment, 201206 investment of an additional sum by BRAIN AG |
2012-06-08 |
| Merck (DE)–Dr. Reddy’s: biosimilars, 201206– collab co-development + manufacturing + commercialisation ww with exceptions Merck Serono |
2012-06-06 |
| Duzem–Bruker Corp: mass spectrometer, 201206– supply exclusive long-term agreem to equip Duzen labs with MALDI Biotyper systems |
2012-06-05 |
| BRAIN–Germany (govt): grant, 201206– funding from BMBF for up to 9y as partner + coordinator of NatLifE 2020 alliance |
2012-06-01 |
| Bayer–Covance: clinical research services, 201205– supply strategic alliance incl phase 2–4 studies + central lab services for Bayer HealthCare |
2012-05-30 |
| AudioCure Pharma–High-Tech Gründerfonds: investment, 201205 seed financing from HTGF + business angel Dr Schumacher |
2012-05-29 |
| AudioCure Pharma–SEVERAL: investment, 201205 seed financing from High-Tech Gründersfonds + business angel Dr Schumacher |
2012-05-29 |
| TU Munich–Nonlinear Dynamics: mass spectrometry s/w, 201205 supply existent use of Progenesis LC-MS s/w by Prof Küster |
2012-05-21 |
| BioPlanta–Vita 34: investment, 201205 acquisition in shares with 380k new shares issued to BioPlanta owner + founder André Gerth |
2012-05-16 |
| Evotec–Agilent: mass spectrometer, 201205 supply 6460 Triple Quadrupole instrumentation to Hamburg facility |
2012-05-16 |
| Evotec–Agilent: mass spectrometer, 201205 supply multiple RapidFire High-throughput MS systems to Hamburg facility |
2012-05-16 |
| Cellzome–GSK: investment, 201205 acquisition remaining 80% for £61m ($99m) in cash |
2012-05-15 |
| Genome Diagnostics–Qiagen: PCR technology, 201205– distribution rights ww non-excl for Qiagen LongRange PCR kit together with SBTexcellerator reagents |
2012-05-15 |
| Ono Pharmaceutical–Coral BioNet: Affilin therapeutics, 201205– collab discovery + developm Affilin molecules against Ono targets with Scil Proteins |
2012-05-15 |
| T-Cell Europe–High-Tech Gründerfonds: investment, 201205 1st financing round totalling €1.45m incl HTGF |
2012-05-15 |
| T-Cell Europe–SEVERAL: investment, 201205 1st financing round €1.45m from HTGF + Constantin Bastian Leander Venture Capital + ILB |
2012-05-15 |
| Algiax Pharmaceuticals–High-Tech Gründerfonds: investment, 201205 financing round totalling €4.3m incl HTGF + private investors + KfW |
2012-05-14 |
| Algiax Pharmaceuticals–SEVERAL: investment, 201205 financing round €4.3m from HTGF + private investors + KfW |
2012-05-14 |
| Fresenius–SEVERAL: investment, 201205 capital increase €1b placement of 13.8m new ordinary shares €73.5/share |
2012-05-11 |
| Evotec–4-Antibody: antibody drug discovery, 201205– collab integration of output from Rectrocyte Display technology into Ab drug discovery services |
2012-05-09 |
| Bayer–Two Blades Foundation: TAL Code technology, 201205– non-excl commercial license €na to Bayer CropScience commercial use in certain crop plants |
2012-05-01 |
| BF Holding–MC Services: public relations, 201205– service public + investor relations for MagForce AG |
2012-05-01 |
| Two Blades Foundation–Univ Halle: TAL Code technology, 201205 excl license for commercial use in plants existent |
2012-05-01 |
| Cardinal Health–Qiagen: molecular diagnostics, 201204– distribution of Qiagen systems + kits to smaller + mid-sized US hospitals by Cardinal Health |
2012-04-30 |
| Active Biotech–Evotec: drug discovery services, 201204– service €na expansion medicinal chemistry services drug optimisation |
2012-04-26 |
| Futalis–High-Tech Gründerfonds: investment, 201204 seed financing from HTGF |
2012-04-26 |
| Rhön-Klinkum–Fresenius: investment, 201204–201206 NOT REALISED cash tender offer €3.1b €22.5/share OFFER FAILED |
2012-04-26 |
| JnJ–Artes Biotechnology: cell line development, 201204– collab developm + supply of Hansenula cell lines to Crucell for two vaccines |
2012-04-24 |
| ConoGenetix–Bavaria (govt): investment, 201204 financing round Series A totalling €1.5m incl returning investor BioM AG |
2012-04-23 |
| ConoGenetix–Mey Capital Matrix: investment, 201204 financing round Series A totalling €1.5m incl lead investor Mey Capital Matrix GmbH |
2012-04-23 |
| ConoGenetix–SEVERAL: investment, 201204 financing round Series A €1.5m lead investor Mey Capital Matrix + co-investor BioM AG |
2012-04-23 |
| AJ Roboscreen–Analytik Jena: investment, 201204 acquisition of remaining shares with resulting 100% ownership by Analytik Jena AG |
2012-04-20 |
| KonTEM–High-Tech Gründerfonds: investment, 201204 investment by HTGF |
2012-04-17 |
| Oncgnostics–High-Tech Gründerfonds: investment, 201204 seed funding from HTGF + STIFT |
2012-04-16 |
| Oncgnostics–SEVERAL: investment, 201204 seed funding from HTGF + STIFT |
2012-04-16 |
| Oncgnostics–Thuringia (govt): investment, 201204 seed funding from HTGF + STIFT |
2012-04-16 |
| Bayer–KWS: plant breeding, 201204– collab co-developm breeding of herbicide-resistant varieties for weed control system Bayer CropScience |
2012-04-12 |
| Bipharma–Biofrontera: 5-aminolevulinic acid, 201204– excl marketing + distribution of Ameluz in Benelux by Bipharma NV |
2012-04-04 |
| ZIM Plant Technology–High-Tech Gründerfonds: investment, 201204 investment by HTGF |
2012-04-04 |
| Henkel–4SC: compound screening, 201204– collab computerised screening to identify laundry detergent ingredients 4SC Discovery GmbH |
2012-04-02 |
| Bayer–Piramal: investment, 201204 acquisition of molecular imaging business from Bayer Healthcare |
2012-04-01 |
| Thermo Fisher–Peak Scientific: gas generator, 201203 collab Genius 1022 nitrogen generator specifically developed for Thermo’s Q Exactive system |
2012-03-30 |
| Allergan–Biofrontera: 5-aminolevulinic acid, 201203– excl marketing + distribution of Ameluz in Spain by Allergan |
2012-03-29 |
| Altona Diagnostic–EU (govt): grant, 201203– EFRE funding €4.63m for ADT + BNI for €9m joint tropical disease project |
2012-03-29 |
| Altona Diagnostic–Hamburg (govt): grant, 201203– funding €400k for ADT + BNI for €9m joint tropical disease project |
2012-03-29 |
| Altona Diagnostic–Leibniz-Gemeinschaft: molecular diagnostics, 201203– collab tropical diasease biobank + developm of respective tests ADT + BNI |
2012-03-29 |
| Leibniz-Gemeinschaft–EU (govt): grant, 201203– EFRE funding €4.63m for ADT + BNI for €9m joint tropical disease project |
2012-03-29 |
| Leibniz-Gemeinschaft–Hamburg (govt): grant, 201203– funding €400k for ADT + BNI for €9m joint tropical disease project |
2012-03-29 |
| GATC Biotech–Hamilton: laboratory automation equipment, 201203 supply existent fleet of Hamilton robotics at GATC Cologence Sequencing Centre |
2012-03-28 |
| Promethera–Boehringer: investment, 201203 financing round Series B totalling €17m incl new investor Boehringer Ingelheim Venture Fund |
2012-03-28 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2011.jpg){kind=logo}
1 2 3 4 ... 56 57 58 
Date
![Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
